- Chemours reported Q4 2024 net sales of $1.36 billion, down 1% year-over-year, driven by a 3% decrease in pricing partially offset by a 2% increase in volume.

- Q4 adjusted EBITDA was $179 million, up 2% year-over-year, driven by cost savings from the TT Transformation Plan, favorable inventory adjustments and higher volumes in TSS, partially offset by lower pricing.

- For full year 2024, net sales were $5.78 billion, down 5% year-over-year due to lower pricing and portfolio changes, while adjusted EBITDA was $786 million, down 22% due to lower pricing, unfavorable currency impacts and higher costs.

- The company provided 2025 adjusted EBITDA guidance of $825-$975 million, expecting growth in Opteon Refrigerants and cost savings from the Pathway to Thrive strategy.